Hepregen Corporation

Hepregen focuses on advancing and commercializing its HepatoPac microliver platform for pharmaceutical and biotechnology company drug-development pipelines.

Biotechnology Research

Explore the company ↓Explore its lists ↓

Headquarters: Medford, Massachusetts, United StatesSource: RevenueBaseRetrieved October 13, 2026
Employee range: 11 to 50Source: RevenueBaseRetrieved October 13, 2026
Founded: 2007Source: RevenueBaseRetrieved October 13, 2026
Published list appearances: 5 supported appearances ↗Source: RevenueBase lists

The company at a glance

What does Hepregen Corporation do?

HepatoPac is an in vitro human liver model and micro-patterned co-culture, optimized and miniaturized in multi-well formats using adapted microtechnology tools. HepatoPac is designed to fit existing workflows and support high-content screening in preclinical DMPK and safety analysis.

Based on the company’s public LinkedIn information, supplied through RevenueBase.

Who it serves

Hepregen is partnered with pharmaceutical companies using its HepatoPac technology.

What the business offers

Services & capabilities.

Toxicity screening and drug discovery

Hepregen’s technology is offered as a potentially more predictive platform for toxicity screening and drug discovery.

Source: LinkedIn company description · Retrieved October 13, 2026

Liver drug assessment and research applications

HepatoPac can be used to assess efficacy of drugs affecting the liver, identify biomarkers, create diseased liver models, and work with stem cells.

Source: LinkedIn company description · Retrieved October 13, 2026

Explore the business in context

Snapshot: September 19, 2026

↗

Positions describe ordering within each source list. See how lists are built ↗

Share your recognition

Embeddable award for your website

BADGE PREVIEW

Open the published source list.

Hepregen Corporation

#14 Human intestinal chip makers

Snapshot: September 19, 2026

Display size

Download SVG

Copy this code into your website

<a href="https://revenuebase.ai/companies/human-intestinal-chip-makers/united-states" target="_blank" rel="nofollow noopener">
  <img src="https://revenuebase.ai/companies/profiles/hepregen/recognition-companies-human-intestinal-chip-makers-united-states-20260920-eddfafcc321900d1346e3d70ece6f115f362c9ebe92d2e62b610cece36328def.svg" alt="Hepregen Corporation listed #14 on Human intestinal chip makers, September 19, 2026" width="220" height="319" style="max-width:100%;height:auto;" />
</a>

View live list ↗

Sources & data notes.

RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 15, 2026, September 18, 2026 and September 19, 2026. How the company lists are built.

Help keep this profile accurate

Something changed?

Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.

Request an update ↗

Find your next account

One company is just the start.

Explore more companies by name, headquarters and business focus.

Explore company profiles →